Nicholas Lydon's Net Worth
Nicholas Lydon's net worth is estimated to be at least $10,941,588.08 as of 12/22/2024. CoreStreet's estimation of Nicholas Lydon's net worth is based on their sale of stock and current holding of stock.
Nicholas Lydon is Director at Blueprint Medicines Corp. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 500 units of BPMC stock on 09/17/2020. Their biggest sale was on 04/16/2018 when they sold 33,000 units of AnaptysBio Inc stock for $2,867,040.00. They typically trade 2 times per year.
Total value of insider buys:
- $249,990.00
Total value of insider sells:
- $10,691,598.08
Most recent insider trade:
- Sept. 17, 2020
Nicholas Lydon's Insider Trading History
| Blueprint Medicines Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 17, 2020 | Director | 500 | $80.00 | Sell | $40,000.00 |
July 6, 2020 | Director | 26,007 | $80.45 | Sell | $2,092,263.15 |
July 2, 2020 | Director | 4,125 | $80.16 | Sell | $330,660.00 |
June 22, 2020 | Director | 13,017 | $80.29 | Sell | $1,045,134.93 |
June 12, 2019 | Director | 25,000 | $84.77 | Sell | $2,119,250.00 |
Feb. 28, 2018 | Director | 25,000 | $87.89 | Sell | $2,197,250.00 |
| AnaptysBio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 16, 2018 | Director | 33,000 | $86.88 | Sell | $2,867,040.00 |
Jan. 31, 2017 | Director | 16,666 | $15.00 | Buy | $249,990.00 |